共 50 条
- [41] DAS Does Not Predict Increasing Treatment in Early Rheumatoid Arthritis: Results From the CATCH Study. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S166 - S167
- [43] The PTPN22 polymorphism and the risk of rheumatoid arthritis: Results from the Nurses' Health Study. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S145 - S145
- [45] TOCILIZUMAB DISCONTINUATION AFTER ATTAINING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO WERE TREATED WITH TOCILIZUMAB ALONE OR IN COMBINATION WITH METHOTREXATE: RESULTS FROM A PROSPECTIVE, RANDOMISED, CONTROLLED STUDY (THE SECOND YEAR OF THE SURPRISE STUDY) ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 105 - 106
- [46] Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study) ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (09) : 1268 - 1275
- [47] Preliminary Results From a Controlled Study Assessing the Humoral Immune Response to Vaccines in Rheumatoid Arthritis Patients Treated with Tocilizumab ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S151 - S151